Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines

doi 10.1101/2020.01.27.921312
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cold Spring Harbor Laboratory

Related search

Anti-Gd2 Immunoliposomes for Targeted Delivery of the Survivin Inhibitor Sepantronium Bromide (YM155) to Neuroblastoma Tumor Cells

Pharmaceutical Research
Organic ChemistryBiotechnologyMolecular MedicinePharmacologyPharmaceutical Science
2018English

Establishment of Drug-Resistant Cell Lines as a Model in Experimental Oncology: A Review

Anticancer Research
MedicineCancer ResearchOncology
2019English

YM155 Reverses Statin Resistance in Renal Cancer by Reducing Expression of Survivin

Anticancer Research
MedicineCancer ResearchOncology
2017English

Survivin Selective Inhibitor YM155 Promotes Cisplatin‑induced Apoptosis in Embryonal Rhabdomyosarcoma

International Journal of Oncology
Cancer ResearchOncology
2016English

Phase I and Pharmacokinetic Study of YM155, a Small-Molecule Inhibitor of Survivin

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2008English

A Monoclonal Antibody Detecting Cell Surface Epitope on Some Drug Resistant Human Tumour Cell Lines

British Journal of Cancer
Cancer ResearchOncology
1990English

Molecular Characterisation of Isogenic Taxane Resistant Cell Lines Identify Novel Drivers of Drug Resistance

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

TP53BP2 Decreases Cell Proliferation and Induces Autophagy in Neuroblastoma Cell Lines

Oncology Letters
Cancer ResearchOncology
2019English

Design of a Large-Scale Femtoliter Droplet Array for Single-Cell Analysis of Drug-Tolerant and Drug-Resistant Bacteria

Frontiers in Microbiology
Microbiology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy